Education
About Us
Working with TipRanks
Follow Us
David Baxley Spetzler Insider Profile
4 Followers
David Baxley Spetzler, President at Caris Life Sciences, Inc., holds 460.78K shares in Caris Life Sciences, Inc. (Ticker: CAI). Most recently, David Baxley Spetzler Bought 400 shares of Caris Life Sciences, Inc. on Nov 10, 2025 for an estimated value of $9.54K.
David Baxley Spetzler has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David Baxley Spetzler's holdings
Insider Roles
President
Roles that David Baxley Spetzler holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Baxley Spetzler
David Baxley Spetzler's Trading History
List of latest transactions for each holding click on a transaction to see David Baxley Spetzler's performance on stock
You May Also Like
David Baxley Spetzler insider profile FAQ
What is the percentage of profitable transactions made by David Baxley Spetzler?
The percentage of profitable transactions made by David Baxley Spetzler is ―.
What is the average return per transaction made by David Baxley Spetzler?
The average return per transaction made by David Baxley Spetzler is ―.
What stocks does David Baxley Spetzler hold?
David Baxley Spetzler holds: CAI stocks.
What was David Baxley Spetzler’s latest transaction?
David Baxley Spetzler latest transaction was an Informative Buy of $9.54K.
What was David Baxley Spetzler's most profitable transaction?
David Baxley Spetzler’s most profitable transaction was an Informative Buy of CAI stock on November 10, 2025. The return on the trade was -3.80%.
What is David Baxley Spetzler's role in Caris Life Sciences, Inc.?
David Baxley Spetzler's role in Caris Life Sciences, Inc. is President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.